CANINE VACCINES

Brand	Owner (click to sort)	Address	Description
CLASSIC CANINE	SYNBIOTICS CORPORATION	11011 Via Frontera San Diego CA 92127	CANINE VACCINES;CANINE;
CLASSIC CORONA	SYNBIOTICS CORPORATION	11011 Via Frontera San Diego CA 92127	canine vaccines;CORONA;
DURAMUNE ADULT	ELANCO US INC.	2500 INNOVATION WAY GREENFIELD IN 46140	canine vaccines;DURABLE IMMUNE ADULT;ADULT;
EHRLICHIAVAX	WYETH	Five Giralda Farms Madison NJ 07940	canine vaccines;
NARAMUNE-2	PHILIPS ROXANE, INC.	New York NY	CANINE VACCINES;
SENTRYVAC	SYNBIOTICS CORPORATION	11011 Via Frontera San Diego CA 92127	canine vaccines;SENTRY VAC, SENTRY VACCINES;
SENTRYVAC DHP	SYNBIOTICS CORPORATION	11011 Via Frontera San Diego CA 92127	canine vaccines;SENTRY VAC DHP, SENTRY VACCINE DHP;DHP;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The present invention relates to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins; to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF nucleic acid molecules, including those that encode canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins, respectively; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.